Sunday, August 13, 2017 1:44:15 PM
"These findings are particularly relevant in light of the 21st Century Cures Act implemented last December, which aims to speed up the drug approval process through several new or expanded pathways. According to the study authors, this has led to concerns that expedited review will become the rule rather than the exception for new drugs."
http://www.ajmc.com/newsroom/drugs-receiving-fda-expedited-review-produce-greater-health-benefits-study-finds
&
Senate passes right to try law last week.
https://www.bioedge.org/bioethics/us-senate-passes-right-to-try-law/12383
Everything is in my own opinion. Do what you think is right.
FEATURED ZenaTech, Inc. (NASDAQ: ZENA) Launchs IQ Nano Drone for Commercial Indoor Use • Oct 10, 2024 8:09 AM
FEATURED CBD Life Sciences Inc. (CBDL) Targets Alibaba as the Next Retail Giant for Wholesale Expansion of Top-Selling CBD Products • Oct 10, 2024 8:00 AM
Foremost Lithium Announces Option Agreement with Denison on 10 Uranium Projects Spanning over 330,000 Acres in the Athabasca Basin, Saskatchewan • FAT • Oct 10, 2024 5:51 AM
Element79 Gold Corp. Reports Significant Progress in Community Relations and Development Efforts in Chachas, Peru • ELEM • Oct 9, 2024 10:30 AM
Unitronix Corp Launches Share Buyback Initiative • UTRX • Oct 9, 2024 9:10 AM
BASANITE INDUSTRIES, LLC RECEIVES U.S. PATENT FOR ITS BASAFLEX™ BASALT FIBER COMPOSITE REBAR AND METHOD OF MANUFACTURING • BASA • Oct 9, 2024 7:30 AM